We conducted a hospital-based case–control study, including 384 patients with LC and 851 controls without any liver diseases, to assess the association between 264 polymorphisms in AT3 and AFB1-related LC risk. The gene discussed is ATXN3; the disease is laryngotracheoesophageal cleft.